Results 21 to 30 of about 867 (83)

Real‐world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 38, Issue 3, Page 530-542, March 2024.
Abstract Background Evidence on the (long‐term) safety of systemic immunomodulating therapies in atopic dermatitis (AD) generated by real‐world data is sparse. Objectives To describe real‐world reported adverse drug reactions (AEs) related to systemic immunomodulating therapy in patients with AD and to compare the incidence rates of AEs with the ...
A. H. Musters   +11 more
wiley   +1 more source

Transcanthal Canthopexy for Involutional Lower Eyelid Entropion Corrects Horizontal Laxity

open access: yesJournal of Ophthalmology, Volume 2024, Issue 1, 2024.
In this prospective observational study, we aimed to examine improvements in horizontal laxity after lower eyelid retractor advancement and transcanthal canthopexy for involutional lower eyelid entropion. The study included 19 sides in 15 patients with involutional entropion who underwent transcanthal canthopexy with the advancement of the lower eyelid
Shinjiro Kono   +2 more
wiley   +1 more source

Short-term qualitative and quantitative analyses of preseptal injection of hyaluronic acid on the treatment of acquired lower eyelid cicatricial ectropion. [PDF]

open access: yesArq Bras Oftalmol, 2023
Veloso LK   +6 more
europepmc   +1 more source

Cicatricial ectropion due to allergic dermatitis.

open access: yesOman J Ophthalmol, 2021
Mukherjee B, Giratkar S.
europepmc   +1 more source

Cicatricial ectropion secondary to psoriatic arthritis. [PDF]

open access: yesCase Rep Ophthalmol Med, 2015
Gracitelli CP   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy